Business Standard Easing pricing pressures, complex generics uptick in the US, steady India/emerging-market growth potential booster shots Topics
Nifty Pharma | Pharma sector | US markets
Ram Prasad Sahu |
Mumbai
Last Updated at September 26, 2022 06:10 IST
Photo: Shutterstock
[…]
The post Prescription for recovery in FY23 for underperforming pharma sector appeared first on The Black Chronicle.